Dermata (DRMA) receives Australian patent for topical botulinum toxin treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Dermata (DRMA) receives Australian patent for topical botulinum toxin treatment
(NASDAQ: DRMA) Delayed: 1.14 -0.03 (2.56%)
Previous Close $1.17    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.20    P/E N/A 
Day Low $1.13    EPS $ 
Volume 30,295       

(NASDAQ: DRMAW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High $ 
Open $0.00    52 Week Low $ 
Day High $0.00    P/E N/A 
Day Low $0.00    EPS $ 
Volume 516,885